"Analysis of reimbursement (R) for next generation sequencing (NGS) on patients' tumors in the context of a personalized medicine program." by Thomas D. Brown

Selected Works of John M. Pagel, MD, PhD

Article

Analysis of reimbursement (R) for next generation sequencing (NGS) on patients' tumors in the context of a personalized medicine program.

Journal of Clinical Oncology (2017)

Thomas D. Brown, University of Texas Health Science Center at San Antonio
Mariko Tameishi
Xiaoyu Liu
James Scanlan, University of Washington
J. David Beatty, Cancer Institute
Charles Drescher, Fred Hutchinson Cancer Research Center
John M. Pagel, Cancer Institute
Philip Jordan Gold, Cancer Institute
Shlece Alexander
Lauren K. Summers
Madeleine Brindle
Nina Varghis
James Yates
Kathleen N. Fondren
George Richard Birchfield
David Edwin Dong
Tara L. Benkers
Tanya A. Wahl, Fred Hutchinson Cancer Research Center
Scott David Ramsey, Fred Hutchinson Cancer Research Center
Anna Belinda Berry

Link

Disciplines

Publication Date

May 30, 2017

Citation Information

Thomas D. Brown, Mariko Tameishi, Xiaoyu Liu, James Scanlan, et al.. "Analysis of reimbursement (R) for next generation sequencing (NGS) on patients' tumors in the context of a personalized medicine program." Journal of Clinical Oncology (2017)
Available at: http://works.bepress.com/john-pagel/13/